Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Lafyatis

Showing results (101-110 of 196) with videos related to

Pageof 20
Sort By:
Arthritis Research & Therapy|September 5, 2019
A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcersVivek Nagaraja, Cathie Spino, Erica Bush, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2018
Perivascular Adventitial Fibroblast Specialization Accompanies T Cell Retention in the Inflamed Human DermisAlexander M S Barron, Julio C Mantero, Jonathan D Ho, et al.
Journal of Scleroderma and Related Disorders|July 30, 2025
Transcriptomic profiling of scleroderma monocytes reveals links with cardiovascular complications, implicating Notch and interferon pathwaysMehmed T Dinc, Fatima El-Adili, Justin K Lui, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 8, 2021
β-Agonist exposure preferentially impacts lung macrophage cyclic AMP-related gene expression in asthma and asthma COPD overlap syndromeKaveh Moghbeli, Eleanor Valenzi, Rachel Naramore, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2017
Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic SclerosisMichelle Fleury, Anna C Belkina, Elizabeth A Proctor, et al.
Rheumatology (Oxford, England)|December 13, 2024
Elevated Fcy receptor expression augments pro-inflammatory macrophage phagocytosis in systemic sclerosis and associated rheumatic diseasesAmela Hukara, Gino Andrea Bonazza, Tracy Tabib, et al.
Plos One|June 19, 2009
The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypesTimothy R D J Radstake, Lenny van Bon, Jasper Broen, et al.
Annals of the Rheumatic Diseases|July 23, 2013
Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skinAllison L Mathes, Romy B Christmann, Giuseppina Stifano, et al.
Clinical and Experimental Rheumatology|October 3, 2018
Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trialJulio C Mantero, Nina Kishore, Jessica Ziemek, et al.
Respiratory Research|April 21, 2023
Early events marking lung fibroblast transition to profibrotic state in idiopathic pulmonary fibrosisMinxue Jia, Lorena Rosas, Maria G Kapetanaki, et al.
Pageof 20

Showing results (101-110 of 196) with videos related to

Sort By:
Pageof 20
Arthritis Research & Therapy|September 5, 2019
A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcersVivek Nagaraja, Cathie Spino, Erica Bush, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2018
Perivascular Adventitial Fibroblast Specialization Accompanies T Cell Retention in the Inflamed Human DermisAlexander M S Barron, Julio C Mantero, Jonathan D Ho, et al.
Journal of Scleroderma and Related Disorders|July 30, 2025
Transcriptomic profiling of scleroderma monocytes reveals links with cardiovascular complications, implicating Notch and interferon pathwaysMehmed T Dinc, Fatima El-Adili, Justin K Lui, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 8, 2021
β-Agonist exposure preferentially impacts lung macrophage cyclic AMP-related gene expression in asthma and asthma COPD overlap syndromeKaveh Moghbeli, Eleanor Valenzi, Rachel Naramore, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 16, 2017
Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic SclerosisMichelle Fleury, Anna C Belkina, Elizabeth A Proctor, et al.
Rheumatology (Oxford, England)|December 13, 2024
Elevated Fcy receptor expression augments pro-inflammatory macrophage phagocytosis in systemic sclerosis and associated rheumatic diseasesAmela Hukara, Gino Andrea Bonazza, Tracy Tabib, et al.
Plos One|June 19, 2009
The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypesTimothy R D J Radstake, Lenny van Bon, Jasper Broen, et al.
Annals of the Rheumatic Diseases|July 23, 2013
Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skinAllison L Mathes, Romy B Christmann, Giuseppina Stifano, et al.
Clinical and Experimental Rheumatology|October 3, 2018
Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I/II biomarker trialJulio C Mantero, Nina Kishore, Jessica Ziemek, et al.
Respiratory Research|April 21, 2023
Early events marking lung fibroblast transition to profibrotic state in idiopathic pulmonary fibrosisMinxue Jia, Lorena Rosas, Maria G Kapetanaki, et al.
Pageof 20